✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Tretinoin

Tretinoin

CAS 302-79-4C20H28O2MW 300.4

Tretinoin (CAS 302-79-4) — formula C20H28O2, molecular weight 300.4.

Product Overview

CAS Number302-79-4
Molecular FormulaC20H28O2
Molecular Weight300.4
Melting Point354 to 360 °F (NTP, 1992)
LogP6.3
ApplicationsUses: Antineoplastic Agents Keratolytic Agents, MEDICATION, Synthetic Polymer MALDI Matrix Compounds, Use (kg, approx.) in Germany (2009): >10, Use (kg) in USA (2002): 364, Consumption (g per capita, approx.) in Germany (2009): 0.000122, Consumption (g per capita) in the USA (2002): 0.00129, Calculated removal (%): 98.9, For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.), For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage., Methods of Manufacturing: By oxidation of vitamin A aldehyde which may be obtained by oxidation of vitamin A., R. Marbet, German patent 2061507, United States of America patent 3746730 (1971, 1973 both to Hoffmann-La Roche)., Formulations, Preparations: Oral: Capsules 10 mg, Vesanold (Roche), Table: Tretinoin (Topical) Preparations [Table#3901], General Manufacturing Information: Retinoic acid: ACTIVE

Applications

Documented applications: Uses: Antineoplastic Agents Keratolytic Agents, MEDICATION, Synthetic Polymer MALDI Matrix Compounds, Use (kg, approx.) in Germany (2009): >10, Use (kg) in USA (2002): 364, Consumption (g per capita, approx.) in Germany (2009): 0.000122, Consumption (g per capita) in the USA (2002): 0.00129, Calculated removal (%): 98.9, For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.), For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage., Methods of Manufacturing: By oxidation of vitamin A aldehyde which may be obtained by oxidation of vitamin A., R. Marbet, German patent 2061507, United States of America patent 3746730 (1971, 1973 both to Hoffmann-La Roche)., Formulations, Preparations: Oral: Capsules 10 mg, Vesanold (Roche), Table: Tretinoin (Topical) Preparations [Table#3901], General Manufacturing Information: Retinoic acid: ACTIVE.

Technical Profile

What this product is

Tretinoin is a chemical compound with CAS registry number 302-79-4 and molecular formula C20H28O2 (molecular weight 300.4).

Identification

CAS number: 302-79-4

Its molecular formula C20H28O2 comprises 20 C, 28 H, 2 O atoms.

Also known as: Tretinoin · 维A酸

Frequently Asked Questions

What is the CAS number of Tretinoin?

The CAS registry number of Tretinoin is 302-79-4.

What is the molecular formula and molecular weight of Tretinoin?

Molecular formula C20H28O2, molecular weight 300.4.

What other names is Tretinoin known by?

It is also registered under: Tretinoin, 维A酸.

What are the documented applications of Tretinoin?

Recorded applications: Uses: Antineoplastic Agents Keratolytic Agents, MEDICATION, Synthetic Polymer MALDI Matrix Compounds, Use (kg, approx.) in Germany (2009): >10, Use (kg) in USA (2002): 364, Consumption (g per capita, approx.) in Germany (2009): 0.000122, Consumption (g per capita) in the USA (2002): 0.00129, Calculated removal (%): 98.9, For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.), For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage., Methods of Manufacturing: By oxidation of vitamin A aldehyde which may be obtained by oxidation of vitamin A., R. Marbet, German patent 2061507, United States of America patent 3746730 (1971, 1973 both to Hoffmann-La Roche)., Formulations, Preparations: Oral: Capsules 10 mg, Vesanold (Roche), Table: Tretinoin (Topical) Preparations [Table#3901], General Manufacturing Information: Retinoic acid: ACTIVE.

PubChem Public Data

Independent reference data for Tretinoin (CAS 302-79-4), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number302-79-4
PubChem CID444795
Molecular formulaC20H28O2
IUPAC name(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
UNII (FDA)5688UTC01R

Computed descriptors

Molecular Weight300.4
XLogP36.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count5
Exact Mass300.208930132
Monoisotopic Mass300.208930132
Topological Polar Surface Area37.3
Heavy Atom Count22

Physicochemical values on record

Melting Point354 to 360 °F (NTP, 1992)
Melting Point178-184
Melting Point180-182 °C
Melting Point181 °C
LogP6.3
LogPlog Kow = 6.30
LogP6.30
Collision Cross Section182.1 Ų [M+Na]+

Documented uses on record

    Antineoplastic Agents Keratolytic AgentsSynthetic Polymer MALDI Matrix Compounds

    Synonyms and trade names

    Retinoic acid; tretinoin; 302-79-4; all-trans-Retinoic acid; Vitamin A acid; trans-Retinoic acid; ATRA; Aberel; Eudyna; Dermairol; Renova; all-trans-Vitamin A acid; Cordes vas; Retin A; Tretin M; all-trans-Tretinoin

    GHS hazard classification

    Reported hazard statementsH302 (29.8%), H315 (73.4%), H319 (16.5%), H335 (14.9%), H360 (72.9%), H400 (59%), H410 (58%), H411 (16%)

    H302 (29.8%): Harmful if swallowed [Warning Acute toxicity, oral]

    H315 (73.4%): Causes skin irritation [Warning Skin corrosion/irritation]

    What the public record says

    Tretinoin · CAS 302-79-4 · C20H28O2. UNII 5688UTC01R. Melting Point: 354 to 360 °F (NTP, 1992); Melting Point: 178-184; Melting Point: 180-182 °C.

    Physical description and handling notes

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 维A酸

鲁ICP备19031700号-2